BAYRY Stock Recent News

BAYRY LATEST HEADLINES

BAYRY Stock News Image - reuters.com

The U.S. Supreme Court asked President Donald Trump's administration on Monday for its views on Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.

reuters.com 2025 Jun 30
BAYRY Stock News Image - reuters.com

Bayer said on Monday that the U.S. Supreme Court had asked the solicitor general for an opinion in the Durnell case, as the German company seeks clarity from the top U.S. court in litigation related to its weedkiller glyphosate.

reuters.com 2025 Jun 30
BAYRY Stock News Image - globenewswire.com

Following the Bayer-Monsanto merger, litigation has resulted in a valuable settlement that, pending final approval, affirms the rights of ADR investors to

globenewswire.com 2025 Jun 27
BAYRY Stock News Image - invezz.com

Bayer share price has bounced back this year, making it one of the best-performing companies in the German DAX Index. It has jumped to €26, up by 45% from its lowest point this year.

invezz.com 2025 Jun 26
BAYRY Stock News Image - globenewswire.com

Prestigious International Annual Awards Program Honors Standout AI Companies & Solutions Prestigious International Annual Awards Program Honors Standout AI Companies & Solutions

globenewswire.com 2025 Jun 25
BAYRY Stock News Image - zacks.com

BAYRY files for FDA nod to gadoquatrane, a low-dose MRI contrast agent backed by strong QUANTI study results.

zacks.com 2025 Jun 18
BAYRY Stock News Image - businesswire.com

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational contrast agent gadoquatrane for contrast-enhanced magnetic resonance imaging of the CNS and other body regions in adults and pediatric patients including term neonates. The submitted dose is 0.04 mmol gadolinium per kilogram body weight. If approved, gadoquatrane would become the lowest dose macrocyclic GBCA available in the U.

businesswire.com 2025 Jun 17
BAYRY Stock News Image - globenewswire.com

Berlin, Germany – June 17th, 2025 – Captain T Cell GmbH, a biotech company developing next-generation TCR-based cell therapies for patients with solid tumors, today announced that it has been selected for residency in the Bayer Co.Lab incubator in Berlin.

globenewswire.com 2025 Jun 17
BAYRY Stock News Image - zacks.com

In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.

zacks.com 2025 Jun 16
BAYRY Stock News Image - businesswire.com

SAN DIEGO--(BUSINESS WIRE)-- #innovation--Bayer AG Innovation Procurement names Scientist.com as preferred global channel for sourcing external R&D services.

businesswire.com 2025 Jun 16
10 of 50